EUVIMEDEUVIMED entdecken
Crossref

Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis

Hiromi Nishiba, Hisao Imai, Yukiyoshi Fujita, Eriko Hiruta, Takashi Masuno, Shigeki Yamazaki, Hajime Tanaka, Teruhiko Kamiya, Masako Ito, Satoshi Takei, Masato Matsuura, Junnosuke Mogi und 2 weitere

Annals of Palliative Medicine · 2023

DOI: 10.21037/apm-22-1130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Palliative Medicine, 2023. Verfasst von Hiromi Nishiba und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy, Japan Community Health Care Organization (JCHO) Gunma Chuo Hospital, Gunma, Japan; Graduate School of Pharmaceutical Sciences, …. Hauptthemen laut MEDLINE: Opioid-Induced Constipation, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Opioid-Induced ConstipationGastrointestinal NeoplasmsHumansAnalgesics, OpioidRetrospective StudiesConstipationNarcotic AntagonistsNaltrexone

Stichwörter der Autor:innen

Efficacygastrointestinal (GI) cancernaldemedineopioid-induced constipation (OIC)safety

Substanzen

Analgesics, OpioidNarcotic AntagonistsnaldemedineNaltrexone

Autor:innen und Institutionen

  • Division of Pharmacy, Japan Community Health Care Organization (JCHO) Gunma Chuo Hospital, Gunma, Japan; Graduate School of Pharmaceutical Sciences, Takasaki University of Health and Welfare, Gunma, Japan.
  • Department of Respiratory Medicine, Comprehensive Cancer Center, International Medical Center, Saitama Medical University, Saitama, Japan; Division of Respiratory Medicine, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Division of Pharmacy, Gunma Prefectural Cancer Center, Gunma, Japan.
  • Division of Pharmacy, Fujioka General Hospital, Gunma, Japan.
  • Division of Pharmacy, Kiryu Kosei General Hospital, Gunma, Japan.
  • Division of Pharmacy, Haramachi Red Cross Hospital, Gunma, Japan.

Zitieren

APA

Nishiba, H., Imai, H., Fujita, Y., Hiruta, E., Masuno, T., Yamazaki, S., Tanaka, H., Kamiya, T., Ito, M., Takei, S., Matsuura, M., Mogi, J., Obayashi, K., & Minato, K. (2023). Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis. Annals of Palliative Medicine. https://doi.org/10.21037/apm-22-1130

Vancouver

Nishiba H, Imai H, Fujita Y, Hiruta E, Masuno T, Yamazaki S, et al. Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis. Annals of Palliative Medicine. 2023. doi:10.21037/apm-22-1130

BibTeX
@article{Nishiba2023,
  author = {Nishiba, Hiromi and Imai, Hisao and Fujita, Yukiyoshi and Hiruta, Eriko and Masuno, Takashi and Yamazaki, Shigeki and Tanaka, Hajime and Kamiya, Teruhiko and Ito, Masako and Takei, Satoshi and Matsuura, Masato and Mogi, Junnosuke and Obayashi, Kyoko and Minato, Koichi},
  title = {Efficacy and safety of naldemedine treatment for opioid-induced constipation in gastrointestinal cancer: a retrospective analysis},
  journal = {Annals of Palliative Medicine},
  year = {2023},
  doi = {10.21037/apm-22-1130}
}
Kostenlos starten →